Yahoo Web Search

Search results

1. • Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...

     Morningstar· 3 days ago

     With its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts. A recent report from ...

2. • Perosphere Technologies Adds Dr. Michael Grosso to Advisory Board

     Benzinga· 7 days ago

     Perosphere Technologies (Perosphere Technologies Inc.), a private medical technologies company focused on developing next-generation coagulation diagnostics ...

3. • Q4 2024 Sono-Tek Corp Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 3 days ago

     This growth was due to our strategic shift towards these large complex coating systems and platforms and also due to our focus on opening new markets for our unique technology. This includes ...

4. • Robert W. Baird Cuts Nordson (NASDAQ:NDSN) Price Target to $272.00

     ETF DAILY NEWS· 2 days ago

     DA Davidson boosted their target price on Nordson from $290.00 to $315.00 and gave the stock a buy rating in a report on Tuesday, February 27th. KeyCorp reissued a sector weight rating on shares ...

5. • PNC Financial Services Group Inc. Decreases Stock Holdings in AMETEK, Inc. (NYSE:AME)

     ETF DAILY NEWS· 6 days ago

     PNC Financial Services Group Inc. trimmed its stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) by 2.6% in the fourth quarter, according to the company ...

6. • "EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024...

     WTRF Wheeling· 5 days ago

     ZURICH, May 22, 2024 /PRNewswire/ -- Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present ...

7. • BI Asset Management Fondsmaeglerselskab A S Cuts Stake in Mettler-Toledo International Inc....

     ETF DAILY NEWS· 4 days ago

     (NYSE:MTD – Free Report) by 3.5% in the 4th quarter, according to the company in its most...13F filing with the Securities and Exchange Commission. The fund owned 681 shares of the ...

8. • Companion Diagnostic Spoiler Alert: Start at the End Before You Begin, Upcoming Webinar Hosted by...

     PRWeb· 4 days ago

     During the webinar, the speaker will explore the balance between development, commercialization, and the overarching implications for precision medicine therapies. The analysis ...

9. • FDA Grants Withdrawal of Infigratinib for Cholangiocarcinoma

     Medscape· 6 days ago

     The US Food and Drug Administration (FDA) has announced the withdrawal of its 2021 accelerated approval of infigratinib (Truseltiq) for patients with a certain type of previously treated cholangiocarcinoma ...

10. • Evolus (EOLS) Releases Favorable Dermal Fillers Study Data

      Zacks· 6 days ago

      Free Report) has announced favorable results from its pivotal U.S. nasolabial fold (NLF) study of dermal filler products, Evolysse Lift and Smooth. Presented at the 2024 SCALE Meeting, these ...